Inventor · disambiguated record
Ergang Shi
Also filed as: SHI ERGANG
6 granted patents·6 pending applications·294 citations·filing 2003–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0197US7605237B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2007·Granted Oct 20, 2009·194 cites·6 claims
- 0294US8338135B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2011·Granted Dec 25, 2012·33 cites·12 claims
- 0394US8092802B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2010·Granted Jan 10, 2012·33 cites·4 claims
- 0494US7794717B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2009·Granted Sep 14, 2010·34 cites·4 claims
- 0589US2025340672A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0686US2024124613A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0776US2025313624A1Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the sameREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0872US2020377618A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 0971US12371487B2Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the sameREGENERON PHARMA·Filed 2021·Granted Jul 29, 2025·0 cites·39 claims
- 1070US10787522B2VL antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2018·Granted Sep 29, 2020·0 cites·20 claims
- 1159US2015266976A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1243US2004101920A1Modification assisted profiling (MAP) methodologyFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ergang Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →